25 March 2023; Phoenix, AZ USA UPPI President John Witkowski received the 2023 APhA Honorary Membership Award in recognition of his sustained contributions to ensuring the advancement of the nuclear pharmacy profession in the United States. The award recognized Mr. Witkowski’s decades long career in the nuclear pharmacy industry encompassing his role in sales and culminating with his current position as President of UPPI, a nationwide network of independently owned and university based radiopharmacies and cyclotrons. Of particular note was Mr. Witkowski’s work with the United States Department of Energy National Nuclear Security Administration which recognized UPPI for outstanding achievement in support of ensuring reliable supplies of molybdenum-99 produced without the use of highly enriched uranium. Under Mr. Witkowski’s leadership, UPPI’s innovation and initiative through the “LEU Walk” and other efforts demonstrated its dedication to the essential international effort to promote reliable supplies of molybdenum-99 produced without highly enriched uranium for the global marketplace. Further recognition was given by Vizient, the nation’s leading healthcare performance improvement company when it named UPPI its Distributor of the Year in 2017. Most recently, Mr. Witkowski has placed UPPI’s focus on bringing emerging theranostics to patients in the US.
Author Archives: Michelle Thompson
UPPI Annual Meeting to take place September 26-28 2023 in Las Vegas, NV
UPPI is pleased to announce that it will hold its Annual Meeting in Las Vegas, NV this September. UPPI Members and Vendors are encouraged to reach out to Michelle Thompson at firstname.lastname@example.org or Susan Villhauer at email@example.com for information regarding an agenda and hotel accommodations. Looking forward to seeing you there for talks, exhibits, networking and presentations regarding all things radiopharma!
Vizient and UPPI collaborate to write Whitepaper: Can the SPECT nuclear imaging modality be sustained?
The impact of new technology, government and international
regulations, egregious price increases, and collapsing reimbursement structures on the nuclear imaging space
ALK LIFE SCIENCE SOLUTIONS™ STERILE EMPTY VIALS: SUMMARY OF CURRENT SPECIFICATIONS AND IMPLICATIONS OF USP CHAPTER <825> UPDATE
Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM’s platform take
UPPI Sues Cardinal Health in Whistleblower Case Involving “Rent-A-Vet” Scheme
UPPI Participates in Nuclear Regulatory Commission: Regulatory Information Conference
March 9, 2021
Making an Impact: Innovation in the Production of Medical Radioisotopes
Session Chair: Brian Smith, Deputy Director Division of Advanced Reactors and Non-Power Production and Utilization Facilities
John Witkowski President UPPI Session Panelist
Significance of a reliable medical isotope supply chain
Mo 99 supply chain resilience in the time of COVID-19 pandemic
Challenges to establishing supply and supply chain resilience
Importance of technology innovation
Impact of medical radioisotope production on the future of the nuclear industry